drugset / Trial / NCT01948011
Racecadotril Suspension Linearity Study & Comparative Bioavailability Versus Granules
RandomizedCrossoverOpen-label
Summary
To investigate the Racecadotril pharmacokinetic linearity after single oral administration of 10, 30 and 60 mg as a suspension. To evaluate the comparative bioavailability of the new Racecadotril formulation (suspension) versus the reference sachet formulation (granules)
Timeline
- Start
- 2013-09
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Racecadotril | Small molecule | 10 mg | Oral |
| Comparator | Racecadotril | Small molecule | 30 mg | Oral |
| Comparator | Racecadotril | Small molecule | 60 mg | Oral |
Indications
No indication recorded.